• Publications
  • Influence
Evaluation of l-dopa, proximate composition with in vitro anti-inflammatory and antioxidant activity of Mucuna macrocarpa beans: A future drug for Parkinson treatment
Abstract Objective To investigate L -3, 4-dihydroxyphenylalanine ( l -dopa, anti-Parkinson drug), anti-inflammatory activity, proximate nutritional composition and antioxidant potential of MucunaExpand
  • 8
  • 1
Karyotype studies in Mucuna macrocarpa Wall and Mucuna sanjappae Aitawade et Yadav (Fabaceae) from India
The genus Mucuna Adans. is represented by 100 species distributed in the world tropics (Lackey 1981; Mabberley 2005). India is one of the natural center of origin of Mucuna. Up to now there are 11Expand
  • 2
  • PDF
RP-HPLC Analysis of Anti-Parkinson’s Drug l-DOPA Content in Mucuna Species from Indian Subcontinent
Genus Mucuna has tremendous value in the Indian Ayurveda, and the species have been used for the management of diseases including Parkinson’s disease. Unfortunately, species other than M. pruriensExpand
  • 2
Mucuna laticifera, a new species from north-eastern India
Mucuna laticifera, a new species of Fabaceae from Sikkim state of India is described and illustrated here. It can be distinguished from its closely related species by the presence of a watery latex,Expand
  • 2
  • PDF
Exploring the proximate composition, antioxidant, anti-Parkinson's and anti-inflammatory potential of two neglected and underutilized Mucuna species from India
Abstract Mucuna, a treasured leguminous genus is renowned for its high L-DOPA (L-3, 4-dihydroxyphenylalanine) content which acts as an effective anti-Parkinson's drug. Unfortunately, the immenseExpand
  • 2